Brief: BioInvent Q2 Sales SEK 12.8 Million
27/08/2026 07:02
BRIEF-BioInvent Q2 Sales SEK 12.8 Million Aug 27 (Reuters) - BioInvent Q2 adjusted free cash flow SEK -112 million.
- Q2 net income SEK -122.9 million
- Q2 adjusted EPS SEK -1.87
BINV — BioInvent International AB News Story
0.000.00%
Last trade - 00:00- SEK1.55bn
- SEK1.23bn
- SEK226.50m